Aggamin
Aggamin Biologics is a biotechnology company developing biologic drugs for unmet medical needs.
Business Model:
Revenue: $0
Employees: 1-10
Rankings
Industries / Tags:
Detailed Aggamin Information
Geographic Data
Address: 101 Avenue of the Americas
City: New York
State: NY
Zip: 10013
Country: US
Financial Info
Stage:
series unknown
Raised Last:
$4M
Raised Total:$8M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Aggamin is an early-stage biotechnology company founded in early 2010 to develop and commercialize therapies for a variety of vascular diseases. The lead program is focused on preeclampsia — a currently untreatable disease affecting 5% of pregnancies with an annual cost to the U.S health care system of $10 billion. Lead product is an extracorporeal device for preeclampsia that reduces circulating pathogenic proteins to improve maternal and fetal health. The company objectives are to manufacture and commercialize the preeclampsia device as a safe first-in-class treatment for preeclampsia that will control maternal symptoms and extend pregnancy, thus improving both maternal and neonatal outcomes.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 4/2013 | Venture Round | $3.7M | 1/2011 | Debt Financing | $300k | 1/2013 | Series A | $2.3M | 10/2011 | Debt Financing | 1 | $1.4M |
Broadview Ventures Broadview Ventures |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
